About Enveda
Enveda is a company based in Boulder (United States) founded in 2019.. Enveda has raised $504.46 million across 11 funding rounds from investors including Microsoft, SVB and Sanofi. The company has 103 employees as of March 28, 2024. Enveda offers products and services including Enveda Platform. Enveda operates in a competitive market with competitors including Aqemia, NTxBio, Nimble Therapeutics, Applied BioMath and IMIDomics, among others.
- Headquarter Boulder, United States
- Employees 103 as on 28 Mar, 2024
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Enveda Therapeutics India Private Limited
- Date of Incorporation 08 Aug, 2019
- Jurisdiction Visakhapatnam, Andhra Pradesh, India
-
Annual Revenue
$3.94 M (USD)117.1as on Mar 31, 2023
-
Net Profit
$683.67 K (USD)90.72as on Mar 31, 2023
-
EBITDA
$1.31 M (USD)142.74as on Mar 31, 2023
-
Total Equity Funding
$504.46 M (USD)
in 11 rounds
-
Latest Funding Round
$150 M (USD), Series D
Sep 04, 2025
-
Investors
Microsoft
& 31 more
-
Employee Count
103
as on Mar 28, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Enveda
Enveda offers a comprehensive portfolio of products and services, including Enveda Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform analyzes natural molecules for faster medicine development
Funding Insights of Enveda
Enveda has successfully raised a total of $504.46M across 11 strategic funding rounds. The most recent funding activity was a Series D round of $150 million completed in September 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 11
- Last Round Series D — $150.0M
-
First Round
First Round
(01 Jan 2019)
- Investors Count 32
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2025 | Amount | Series D - Enveda | Valuation | Premji Invest | |
| Feb, 2025 | Amount | Series C - Enveda | Valuation |
investors |
|
| Nov, 2024 | Amount | Series C - Enveda | Valuation | Kinnevik , FPV Ventures |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Enveda
Enveda has secured backing from 32 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include Microsoft, SVB and Sanofi. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments are directed toward multiple sectors by Kinnevik.
|
Founded Year | Domain | Location | |
|
Provides venture capital for technology startups and enterprise innovations worldwide.
|
Founded Year | Domain | Location | |
|
Seed and early-stage technology companies are funded by Lux Capital.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Enveda
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Enveda
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Enveda Comparisons
Competitors of Enveda
Enveda operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Aqemia, NTxBio, Nimble Therapeutics, Applied BioMath and IMIDomics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutic molecules are discovered through AI and quantum physics integration.
|
|
| domain | founded_year | HQ Location |
Provider of bio informatics platform to develops biologics and therapeutics
|
|
| domain | founded_year | HQ Location |
Combinatorial chemistry services for peptide-based drug discovery are provided.
|
|
| domain | founded_year | HQ Location |
Systems biology and pharmacology modeling services to aid drug discovery and development
|
|
| domain | founded_year | HQ Location |
Precision medicines for immune-mediated inflammatory diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Enveda
Frequently Asked Questions about Enveda
When was Enveda founded?
Enveda was founded in 2019.
Where is Enveda located?
Enveda is headquartered in Boulder, United States. It is registered at Boulder, Colorado, United States.
Is Enveda a funded company?
Enveda is a funded company, having raised a total of $504.46M across 11 funding rounds to date. The company's 1st funding round was a Series C of $130M, raised on Jan 01, 2019.
How many employees does Enveda have?
As of Mar 28, 2024, the latest employee count at Enveda is 103.
What is the annual revenue of Enveda?
Annual revenue of Enveda is $3.94M as on Mar 31, 2023.
What does Enveda do?
Enveda was founded in 2019 in Boulder, United States, as a biotechnology company focused on drug discovery. Advanced computational methods and metabolomics are employed by the platform to analyze natural chemical compounds and identify potential treatments for diseases. Drug development processes are accelerated through the integration of nature-derived chemical insights, supporting research in the pharmaceutical sector.
Who are the top competitors of Enveda?
What products or services does Enveda offer?
Enveda offers Enveda Platform.
Who are Enveda's investors?
Enveda has 32 investors. Key investors include Microsoft, SVB, Sanofi, Baillie Gifford, and Allen & Company.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.